Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wouldn't be surprised if the annual report shows 2021 revs that exceeds the current market cap, with a very solid net profit as well
I don't know that they need more funding. They've already raised $50 million. Dermatology drugs are some of the lesser expensive drugs to fund through clinical trials.
Our time will come. We have an excellent CEO he can sure never be accused of pumping his stock lol
Recent article about the booming biotech industry in India. Vyome is mentioned as one of the prominent companies.
https://www.ciol.com/indian-biotech-startups-ecosystem-unfolding-new-chapter/
"Bugworks Research, Vyome Therapeutics, MedGenomes, GIANT Labs, Fours Healthcare, Sattva MedTech, Indian Immunologist Limited (IIL), Biological E. Limited (BE), and Mankind Pharma are the prominent biotech companies.
A cluster of angel investors is implanting into India’s innovative biotech sector. An ample of tech-medical startups are receiving funding from different Indian state government ministries and overseas. The blend of R & D and IT-friendly natural habitats is significant for the industry.
All innovative biotechpreneurs are encouraged by the schemes of the Indian government like—Department of Biotech India, Niti Ayog, Atal Innovation Mission, Startup India, Invest India, Skill India, Dept of Science and Technology, Gov. of India and BIRAC are the ecosystem of Indian biotech startups."
Thanks for the update. My fear is that we would get a rug pull like has happened with a couple other promising mergers recently. Looks like we are good here just need to wait.
Solid day here. Volume is increasing
Nice one. Sure is thin
Low volume take down
Nice volume past 2 sessions. Accumulation at an ATH
Awesome. Time to move back up
Well, a 33,000 share buy just pushed the price up 17% lol it's thin as a razor
In an interview from a couple years ago Venkat said they were looking at different options for going public. I can't see this as being anything other than that, Vyome reverse merging fully into the LICH shell. I agree we will one day wake up to the big confirmation of the merger along with their corporate roadmap
Nice news smart move by the company
Yield sign is up. I guess that will be corrected when Q1 is released...or maybe because Nevada SOS still isn't updated
Yes and one of their top portfolio managers is chairman of the board for Vyome
All the company has to do is introduce themselves and lay out their vision and this will fly past .10!
Agree. Really good action on a friday
Strong close and good volume again today, preppin for the run to dollars
Yes he does not sure what he's waiting for...
Getting some volume here. Looking good.
Shah no longer owns those shares or has less than 5%. According to the last annual report the only significant or beneficial shareholder/insider is Venkat Nelabhotla. Maybe they bought him out along with the others.
We got a little taste today of just how easily this can fly and go straight parabolic, and it will
Happy New Year it's going to be a great one for LICH and Vyome Therapeutics
Nice! Their patent portfolio alone should value this well over $100 million market cap. Compare to other clinical stage biopharma stocks like Myovant and Tarsus trading on NYSE and Nasdaq. Vyome has a larger patent portfolio than both of those companies. Expecting a massive move toward a proper valuation when all comes to light.
Definitely huge run imminent here
Can't believe how thin this is when a trade of 10k shares can move it 10% higher wow
Yep just need to hear from the company now
Boom! This is so freaking thin and set to explode
Yield sign came off Pink Current today, something is coming in here.
Sure looks like it is
Up 23% on a low volume day, I'll take it ;)
All I want for Christmas is a PR lol
They've been planning this for quite some time. In an interview in 2019 the CEO said they were looking at "options" to become a publicly traded company. This is the culmination of those efforts. They're certainly not going to drop the ball now. I don't mind waiting however long it takes but I suspect we will be getting that big first PR soon.
Nice work! Management here are top notch professionals. He responded to my email in a similar fashion
I agree, a symbol change would bring more clarity and increase visibility to potential investors
I hope they update or are in the process of updating Nevada SOS soon. Maybe they are waiting for that to be finalized before releasing a PR.
This is an advanced clinical stage biotech merging in here, not some thrown together flavor of the day pump merger like most others. A rare opportunity on the OTC imo.
Some profit taking today. Flippers get tf out time to move back up
Will hit silver right out the gate and wouldn't be surprised to see .10-.15 cents next week
100% agree this will shock the entire OTC. There are no other clinical stage biotechs with comparable drug pipelines and patent portfolios that are trading at less than 100s of millions to billion+ dollar market caps and we are still under 10 million.